This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Symphytum x uplandicum
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
Hybrid comfrey with higher pyrrolizidine alkaloid content; used topically for musculoskeletal conditions.
Hybrid comfrey with higher pyrrolizidine alkaloid content; used topically for musculoskeletal conditions. Key active compounds include allantoin, pyrrolizidine alkaloids, mucilage.
allantoin, along with pyrrolizidine alkaloids and mucilage, are the primary bioactive compounds in Symphytum uplandicum. These compounds modulates NF-κB and COX-2 inflammatory pathways, acts on pain pathways via anti-inflammatory and neuroactive effects.
Topical analgesic
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-inflammatory cream
Muscle pain
Based on traditional use; clinical evidence limited
Joint inflammation
Based on traditional use; clinical evidence limited
Bruises
Based on traditional use; clinical evidence limited
Bone healing
Based on traditional use; clinical evidence limited
Found an error or have a correction for Symphytum uplandicum?
Report an Issue →